Abstract
Neuropathic pain is a chronic condition that causes long-term burning sensations. Despite significant efforts, current treatments for neuropathic pain are ineffective in curing the condition, which means new therapeutic options must be developed. One such option is the use of stem cell therapy in combination with anti-inflammatory herbal components, which has shown promise in treating neuropathic pain. The study aimed to investigate the effects of bone marrow mesenchymal stem cells (BM-MSCs) with luteolin on sensory deficits and pathological changes in a neuropathic model. The results showed that luteolin, either alone or in combination with BM-MSCs, effectively reduced sensory deficits related to mechanical and thermal hypersensitivity. In addition, luteolin alone and combined with BM-MSCs reduced oxidative stress in neuropathic rats and inhibited cellular responses, particularly reactive astrocytes. The study concluded that combining luteolin and BM-MSCs may offer an effective therapeutic strategy for patients with neuropathic pain, although further research is needed.
Similar content being viewed by others
Data availability
The datasets used for analysis in this study are available upon request from the corresponding author.
Code availability
Not applicable.
References
Asgharzade S, Talaei A, Farkhondeh T, Forouzanfar F (2020) A review on stem cell therapy for neuropathic pain. Curr Stem Cell Res Ther 15:349–361
Austin PJ, Moalem-Taylor G (2010) The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol 229:26–50
Bennett GJ, Xie Y-K (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33:87–107
Bernetti A et al (2021) Neuropathic pain and rehabilitation: a systematic review of international guidelines. Diagnostics 11:74
Calió ML et al (2014) Transplantation of bone marrow mesenchymal stem cells decreases oxidative stress, apoptosis, and hippocampal damage in brain of a spontaneous stroke model. Free Radic Biol Med 70:141–154
Chen G, Park C-K, Xie R-G, Ji R-R (2015) Intrathecal bone marrow stromal cells inhibit neuropathic pain via TGF-β secretion. J Clin Invest 125:3226–3240
Dirscherl K et al (2010) Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype. J Neuroinflammation 7:1–16
Forouzanfar F, Hosseinzadeh H, Khorrami MB, Asgharzade S, Rakhshandeh H (2019) Attenuating Effect of Portulaca oleracea Extract on Chronic Constriction Injury Induced Neuropathic Pain in Rats: An Evidence of Antioxidative and Anti-inflammatory Effects. CNS Neurol Disord Drug Targets 18:342–349
Hara K, Haranishi Y, Terada T, Takahashi Y, Nakamura M, Sata T (2014) Effects of intrathecal and intracerebroventricular administration of luteolin in a rat neuropathic pain model. Pharmacol Biochem Behav 125:78–84
Kamishina H, Deng J, Oji T, Cheeseman JA, Clemmons RM (2006) Expression of neural markers on bone marrow–derived canine mesenchymal stem cells. Am J Vet Res 67:1921–1928
Kempuraj D et al (2021) Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma. Biofactors 47:190–197
Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F III (2011) Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells 29:11–19
Li M, Li Q, Zhao Q, Zhang J, Lin J (2015) Luteolin improves the impaired nerve functions in diabetic neuropathy: behavioral and biochemical evidences. Int J Clin Exp Pathol 8:10112
Mannelli LDC, Cinci L, Micheli L, Zanardelli M, Pacini A, McIntosh JM, Ghelardini C (2014) α-Conotoxin RgIA protects against the development of nerve injury-induced chronic pain and prevents both neuronal and glial derangement. Pain® 155:1986–1995
Miao C, Lei M, Hu W, Han S, Wang Q (2017) A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction. Stem Cell Res Ther 8:1–6
Nabavi SF, Braidy N, Gortzi O, Sobarzo-Sanchez E, Daglia M, Skalicka-Woźniak K, Nabavi SM (2015) Luteolin as an anti-inflammatory and neuroprotective agent: a brief review. Brain Res Bull 119:1–11
Oggu GS, Sasikumar S, Reddy N, Ella KKR, Rao CM, Bokara KK (2017) Gene delivery approaches for mesenchymal stem cell therapy: strategies to increase efficiency and specificity. Stem Cell Rev Rep 13:725–740
Rakhshandeh H, Asgharzade S, Khorrami MB, Forouzanfar F (2021a) Protective effect of Capparis spinosa extract against focal cerebral ischemia-reperfusion. Injury in Rats Cent Nerv Syst Agents Med Chem 21:148–153. https://doi.org/10.2174/1871524921666210625112356
Rakhshandeh H, Ghorbanzadeh A, Negah SS, Akaberi M, Rashidi R, Forouzanfar F (2021b) Pain-relieving effects of Lawsonia inermis on neuropathic pain induced by chronic constriction injury. Metab Brain Dis 36:1709–1716
Rakhshandeh H, Pourbagher-Shahri AM, Hasanpour M, Iranshahi M, Forouzanfar F (2022) Effects of Capparis Spinosa extract on the neuropathic pain induced by chronic constriction injury in rats. Metabolic Brain Disease:1–14
Shehab SAS (2009) Acute and chronic sectioning of fifth lumbar spinal nerve has equivalent effects on the primary afferents of sciatic nerve in rat spinal cord. J Comp Neurol 517:481–492
Siniscalco D, Giordano C, Galderisi U, Luongo L, de Novellis V, Rossi F, Maione S (2011) Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice. Front Integr Neurosci 5:79
Sun T et al (2015) Bone marrow-derived mesenchymal stem cell transplantation ameliorates oxidative stress and restores intestinal mucosal permeability in chemically induced colitis in mice. Am J Transl Res 7:891–901
Swaminathan A, Basu M, Bekri A, Drapeau P, Kundu TK (2019) The dietary flavonoid, luteolin, negatively affects neuronal differentiation. Front Mol Neurosci 12:41
Tibbs GR, Posson DJ, Goldstein PA (2016) Voltage-gated ion channels in the PNS: novel therapies for neuropathic pain? Trends Pharmacol Sci 37:522–542
Udalamaththa VL, Jayasinghe CD, Udagama PV (2016) Potential role of herbal remedies in stem cell therapy: proliferation and differentiation of human mesenchymal stromal cells. Stem Cell Res Ther 7:1–8
Valle-Prieto A, Conget PA (2010) Human mesenchymal stem cells efficiently manage oxidative stress. Stem Cells Dev 19:1885–1893
Vivoli E et al (2010) Acetyl-L-carnitine increases artemin level and prevents neurotrophic factor alterations during neuropathy. Neuroscience 167:1168–1174
Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, Hows JM (2003) Adult bone marrow is a rich source of human mesenchymal ‘stem’cells but umbilical cord and mobilized adult blood are not. Br J Haematol 121:368–374
Yang Y et al (2020) Luteolin alleviates neuroinflammation via downregulating the TLR4/TRAF6/NF-κB pathway after intracerebral hemorrhage biomedicine &. Pharmacotherapy 126:110044
Yousefifard M, Nasirinezhad F, Manaheji HS, Janzadeh A, Hosseini M, Keshavarz M (2016) Human bone marrow-derived and umbilical cord-derived mesenchymal stem cells for alleviating neuropathic pain in a spinal cord injury model. Stem Cell Res Ther 7:1–14
Acknowledgements
This investigation was funded by Vice-Chancellor for Research and Technology, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran (971711).
Funding
This investigation was funded by Vice-Chancellor for Research and Technology, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran (971711). This result is extracted from a M.D. thesis.
Author information
Authors and Affiliations
Contributions
Sajad Sahab Negah and Fatemeh Forouzanfar designed the experiment. Sajad Sahab Negah, Fatemeh Forouzanfar, Mehrdad Hajinejad, Saeideh Nemati, and Seyyed Mohamad Javad Mahdipour Roudbary, did the experiments. Sajad Sahab Negah, Fatemeh Forouzanfar and Mehrdad Hajinejad wrote the paper. Fatemeh Forouzanfar and Sajad Sahab Negah prepared the final draft of the paper.
Corresponding author
Ethics declarations
Ethics approval
The Ethical Committee of MUMS approved the study (971711; ethics approval code: IR.MUMS.MEDICAL.REC.1398.270).
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflicts of interest/Competing interests
The authors have no conflicts of interest to disclose in this study.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Negah, S.S., Hajinejad, M., Nemati, S. et al. Stem cell therapy combined with luteolin alleviates experimental neuropathy. Metab Brain Dis 38, 1895–1903 (2023). https://doi.org/10.1007/s11011-023-01206-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-023-01206-6